Stock listing
NYSE:ANRO Alto Neuroscience, Inc. Stock
Home listing (NYSE) of Alto Neuroscience, Inc.
Follow Alto Neuroscience, Inc. into a list and get an email when it puts out news.
Share price · NYSE:ANRO
$22.70 USD +0.51 (+2.3%)
Close on Nov 3, 2026
- Day range
- $22.40 – $23.14 USDNov 3, 2026
- Volume
- 505,158 sharesNov 3, 2026
- Market cap
- $890.8M USDAt the close on Nov 3, 2026 · price × 39.24M shares outstanding
- 52-week range
- $10.20 – $37.48 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $15.77M USDMedian day 473,638 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:ANRO · Home | $22.70 USD | +0.51 (+2.3%) | 505,158 | $22.71 | $23.14 | $22.40 | $22.19 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NYSE:ANRO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $22.70 | +0.51 | +2.3% | $22.71 | $23.14 | $22.40 | 505,158 | |
| $22.19 | -0.41 | -1.8% | $22.80 | $23.18 | $21.50 | 473,275 | |
| $22.60 | -0.87 | -3.7% | $23.21 | $23.21 | $21.90 | 484,403 | |
| $23.47 | +0.14 | +0.6% | $23.46 | $24.15 | $23.01 | 388,831 | |
| $23.33 | +0.14 | +0.6% | $22.86 | $23.47 | $22.34 | 300,195 | |
| $23.19 | +1.08 | +4.9% | $22.22 | $23.35 | $21.92 | 469,250 | |
| $22.11 | +0.14 | +0.6% | $22.17 | $22.26 | $21.70 | 550,061 | |
| $21.97 | -0.23 | -1.0% | $21.95 | $22.45 | $21.45 | 379,246 | |
| $22.20 | -1.12 | -4.8% | $22.70 | $24.29 | $22.18 | 510,817 | |
| $23.32 | -1.09 | -4.5% | $24.74 | $25.01 | $23.28 | 663,459 | |
| $24.41 | +1.59 | +7.0% | $23.23 | $24.91 | $23.02 | 869,407 | |
| $22.82 | +0.88 | +4.0% | $22.36 | $23.40 | $22.01 | 681,860 | |
| $21.94 | -0.68 | -3.0% | $21.97 | $22.63 | $21.71 | 648,300 | |
| $22.62 | +0.91 | +4.2% | $21.92 | $23.31 | $21.62 | 529,900 | |
| $21.71 | -0.38 | -1.7% | $21.83 | $22.59 | $21.32 | 2,280,100 | |
| $22.09 | -2.06 | -8.5% | $24.04 | $24.20 | $22.07 | 661,800 | |
| $24.15 | -0.22 | -0.9% | $24.34 | $25.25 | $23.86 | 390,300 | |
| $24.37 | +0.34 | +1.4% | $24.00 | $25.11 | $23.81 | 649,400 | |
| $24.03 | +0.51 | +2.2% | $23.03 | $24.05 | $22.81 | 409,800 | |
| $23.52 | -0.17 | -0.7% | $23.39 | $24.42 | $23.33 | 347,900 | |
| $23.69 | -0.32 | -1.3% | $24.06 | $24.70 | $23.50 | 576,300 | |
| $24.01 | -0.79 | -3.2% | $24.63 | $25.85 | $23.80 | 550,300 | |
| $24.80 | -0.51 | -2.0% | $25.64 | $26.10 | $23.87 | 660,700 | |
| $25.31 | -0.22 | -0.9% | $25.50 | $26.49 | $25.12 | 575,800 | |
| $25.53 | -1.05 | -4.0% | $26.87 | $27.41 | $25.53 | 891,600 | |
| $26.58 | -0.08 | -0.3% | $26.44 | $27.42 | $25.75 | 763,400 | |
| $26.66 | +0.17 | +0.6% | $26.36 | $27.76 | $25.89 | 587,000 | |
| $26.49 | -0.69 | -2.5% | $27.36 | $27.62 | $26.48 | 366,300 | |
| $27.18 | -0.32 | -1.2% | $27.51 | $27.91 | $26.39 | 788,400 | |
| $27.50 | -3.28 | -10.7% | $30.39 | $30.62 | $26.41 | 639,900 | |
| $30.78 | +0.15 | +0.5% | $30.71 | $31.46 | $30.18 | 347,100 | |
| $30.63 | +0.36 | +1.2% | $30.64 | $30.81 | $29.80 | 357,800 | |
| $30.27 | -0.71 | -2.3% | $31.32 | $31.65 | $30.08 | 2,199,200 | |
| $30.98 | +0.98 | +3.3% | $30.59 | $31.65 | $30.11 | 411,000 | |
| $30.00 | -0.25 | -0.8% | $30.50 | $31.21 | $29.87 | 548,400 | |
| $30.25 | -1.43 | -4.5% | $31.40 | $31.40 | $29.95 | 420,400 | |
| $31.68 | -0.32 | -1.0% | $31.96 | $32.99 | $31.16 | 453,300 | |
| $32.00 | +0.32 | +1.0% | $32.00 | $33.13 | $31.11 | 415,700 | |
| $31.68 | -2.39 | -7.0% | $33.71 | $34.20 | $31.35 | 790,000 | |
| $34.07 | -1.74 | -4.9% | $35.48 | $36.91 | $33.91 | 556,800 | |
| $35.81 | +0.26 | +0.7% | $34.69 | $36.84 | $34.08 | 580,900 | |
| $35.55 | -0.85 | -2.3% | $36.18 | $36.98 | $35.45 | 269,900 | |
| $36.40 | -0.24 | -0.7% | $36.84 | $37.36 | $35.91 | 324,700 | |
| $36.64 | +1.44 | +4.1% | $35.97 | $37.39 | $35.22 | 432,800 | |
| $35.20 | -0.18 | -0.5% | $35.20 | $36.04 | $34.62 | 350,100 | |
| $35.38 | +0.25 | +0.7% | $34.89 | $35.83 | $33.98 | 764,100 | |
| $35.13 | -1.17 | -3.2% | $35.00 | $35.72 | $34.73 | 246,700 | |
| $36.30 | -0.23 | -0.6% | $36.08 | $36.82 | $35.46 | 359,600 | |
| $36.53 | +0.22 | +0.6% | $35.80 | $36.86 | $34.87 | 282,800 | |
| $36.31 | +0.06 | +0.2% | $36.52 | $37.48 | $35.74 | 474,000 | |
| $36.25 | +1.97 | +5.7% | $33.96 | $36.99 | $33.52 | 867,900 | |
| $34.28 | +0.03 | +0.1% | $34.44 | $35.29 | $33.66 | 291,100 | |
| $34.25 | -0.64 | -1.8% | $34.36 | $34.65 | $33.65 | 313,900 | |
| $34.89 | +0.76 | +2.2% | $35.00 | $35.41 | $33.81 | 335,700 | |
| $34.13 | +0.53 | +1.6% | $33.18 | $34.54 | $33.08 | 433,900 | |
| $33.60 | +1.46 | +4.5% | $32.15 | $34.35 | $31.08 | 863,700 | |
| $32.14 | -0.16 | -0.5% | $31.77 | $32.29 | $29.88 | 874,500 | |
| $32.30 | +3.12 | +10.7% | $30.00 | $33.67 | $29.59 | 989,700 | |
| $29.18 | +0.40 | +1.4% | $28.24 | $29.70 | $28.24 | 278,100 | |
| $28.78 | +0.49 | +1.7% | $28.49 | $29.06 | $27.43 | 228,523 | |
| $28.29 | -0.38 | -1.3% | $28.64 | $29.15 | $27.40 | 417,963 | |
| $28.67 | +0.20 | +0.7% | $29.00 | $29.25 | $27.71 | 336,400 | |
| $28.47 | +0.44 | +1.6% | $27.99 | $29.49 | $27.67 | 421,100 | |
| $28.03 | -0.20 | -0.7% | $28.51 | $28.54 | $27.00 | 248,900 | |
| $28.23 | +0.96 | +3.5% | $27.79 | $28.50 | $27.00 | 555,400 | |
| $27.27 | +0.20 | +0.7% | $27.00 | $27.63 | $25.80 | 409,100 |
- Ticker
- NYSE:ANRO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Latest news
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Nov 3, 2026
Closed $22.70 (+2.3%) on Nov 3, 2026
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
Aug 27, 2026
Closed $35.13 (-3.2%) on Aug 28, 2026
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 12, 2026
Closed $32.30 (+10.7%) on Aug 13, 2026
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
Jul 13, 2026
Closed $28.03 (+5.9%) on Jul 13, 2026
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
Jun 15, 2026
Closed $21.17 (-1.4%) on Jun 15, 2026
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
May 28, 2026
Closed $20.22 (-1.1%) on May 28, 2026
Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award
May 15, 2026
Closed $22.98 (-2.6%) on May 15, 2026
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 13, 2026
Closed $22.85 (-7.2%) on May 13, 2026
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
May 4, 2026
Closed $25.19 (+1.0%) on May 4, 2026
Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
Apr 21, 2026
Closed $25.59 (-6.4%) on Apr 21, 2026
Financings
Registered direct offering of common stock
Jul 13, 2026
Announced: about US$100M · US$26.48 a share · BofA Securities +4
Dealers: BofA Securities (co-lead), Stifel (co-lead), William Blair (co-lead), Baird (co-lead), Jones
Buyers: EcoR1 Capital
Use of proceeds: Accelerate and expand clinical development of ALTO-207, including an additional Phase 3 trial in treatment-resistant depression, and working capital
Decks
TD Cowen 45th Annual Health Care Conference (March 2025)
Conference · 17 slides · Mar 4, 2025
Investor Day (September 2024)
Investor day · 74 slides · Sep 9, 2024
Alto Neuroscience, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 39 in all · newest Nov 3, 2026 · oldest 2025
- Decks
- 2 decks · latest Mar 4, 2025
Where Alto Neuroscience, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:ANRO · Home listing · This page | NYSE | United States | USD |
| BOATS:ANRO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Alto Neuroscience, Inc.